GlobeNewswire (May 1, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
GlobeNewswire (Apr 24, 2013)
-
-
-
GlobeNewswire (Mar 12, 2013)
-
-
GlobeNewswire (Mar 7, 2013)
-
-
GlobeNewswire (Feb 20, 2013)
-
-
-
-
GlobeNewswire (Dec 4, 2012)
-
-
GlobeNewswire (Nov 7, 2012)
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Chelsea Put Sellers Like FDA MoveoptionMONSTER • Mon, Dec 20, 2010
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Pfizer: Is 8 Really Enough?Kevin CC • Fri, May 11, 2012
-
-
-
-
10 Biotech Stocks Positively Correlated To VolatilityKapitall • Thu, Mar 22, 2012
-
Chelsea Therapeutics International Q2 2009 Earnings TranscriptWed, Aug 5, 2009
-
Chelsea Therapeutics International Q1 2009 Call TranscriptWed, May 6, 2009
-
Chelsea Therapeutics International Q4 2008 Earnings Call TranscriptWed, Mar 4, 2009
-
Chelsea Therapeutics Int. Q4 2007 Earnings Call TranscriptTue, Mar 11, 2008
-
GlobeNewswire (May 1, 2013)
-
GlobeNewswire (Apr 24, 2013)
-
GlobeNewswire (Mar 12, 2013)
-
GlobeNewswire (Mar 7, 2013)
-
at MarketWatch.com (Feb 20, 2013)
-
GlobeNewswire (Feb 20, 2013)
-
GlobeNewswire (Dec 4, 2012)
-
GlobeNewswire (Nov 7, 2012)
-
GlobeNewswire (Sep 4, 2012)
-
GlobeNewswire (Aug 8, 2012)
-
GlobeNewswire (Aug 7, 2012)
-
GlobeNewswire (Jul 10, 2012)
-
GlobeNewswire (Jul 3, 2012)
-
at MarketWatch.com (May 31, 2012)
-
GlobeNewswire (May 31, 2012)
CHTP vs. ETF Alternatives
Company Description
We are a development stage pharmaceutical company that seeks to acquire, develop and commercialize innovative products for the treatment of a variety of human diseases. Our strategy is to develop technologies that address important unmet medical needs or offer improved, cost-effective... More
